Page 1

7/16/25 , 3:33 PM Stevanato Group Announces Second Quarter 2021 Financial Results - Establishes Full Year 2021 Guidance - - Stevanato Group SG , Stevanato Group August , 19 2021 Stevanato Group Announces Second Quarter 2021 Financial Results - Establishes Full Year 2021 Guidance - Revenue grew 26 % to € 204.0 million EBITDA increased 52 % to € 61.0 million ; adjusted EBITDA grew 30 % to € 52.4 million Backlog totaled € 738.9 million - PIOMBINO DESE , Italy - [ August 19 , 2021 ] – Stevanato Group S.p.A. ( NYSE : STVN ) , a leading global provider of drug containment , drug delivery , and diagnostic solutions to the pharmaceutical , biotechnology , and life sciences industries , today announced its financial results for the second quarter 2021 and established full- year 2021 guidance . Second Quarter 2021 Highlights ( compared to the same period last year ) and Guidance • Revenue grew 26 % to € 204.0 million ; all growth was organic • Gross margins increased to 31.2 % • Net profit totaled € 34.5 million ; or € 0.14 of diluted earnings per share ( EPS ) and included a non - recurring benefit of € 4.4 million net profit , or € 0.02 diluted EPS • Excluding the one - time benefit , adjusted diluted EPS was € 0.12 https://www.stevanatogroup.com/en/news-events/press-releases/stevanato-group-announces-second-quarter-2021-financial-results/ 1/23